Nalbuphine Hydrochloride Injection, Solution
Product Images NDC 71872-7114

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nalbuphine Hydrochloride (NDC 71872-7114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (7114)

This is a medication known as Nalbuphine HCI Inj which is available in a 10mg/mL 10mL multiple-dose vial. It is used for IV, IM, subcutaneous, or epidural administration and is sterile, non-pyrogenic. It contains sodium cftate, dihyd, citic acid, amongst others. It is stored at a temperature of 20 to 25°C and is manufactured by Mylan Institutional LLC in Lake Forest, USA.*

FDA Label Image

Chemical Structure (Nalbuphine 01)

FDA Label Image

Logo (Nalbuphine 02)

FDA Label Image

Principal Display Panel (10 mg Vial Label)

This is a prescription drug with the NDC code 0409-1464-01. It is a multiple-dose injection that contains nalbuphine HCI, which is used to relieve moderate to severe pain. The drug is sterile and non-pyrogenic and can be used for intravenous, subcutaneous or lumbar routes. It contains buffers, preservatives, and NaCl to adjust the tonicity of the solution. Its usual dosage is indicated in the insert and it should be stored within 20 to 25°C.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.